Frequency of regulatory T cells in renal cell carcinoma patients and investigation of correlation with survival-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Frequency of regulatory T cells in renal cell carcinoma patients and investigation of correlation with survival

Published:2007-05-09 Issue:11 Volume:56 Page:1743-1753
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Griffiths Richard W.,Elkord Eyad,Gilham David E.,Ramani Vijay,Clarke Noel,Stern Peter L.,Hawkins Robert E.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s00262-007-0318-z.pdf

Reference44 articles.

1. Yang JC, Sherry RM, Steinberg SM, Topalian SL, Schwartzentruber DJ, Hwu P, Seipp CA, Rogers-Freezer L, Morton KE, White DE, Liewehr DJ, Merino MJ, et al (2003) Randomized study of high-dose and low-dose interleukin-2 in patients with metastatic renal cancer. J Clin Oncol 21:3127–3132

2. Medical Research Council Renal Cancer Collaborators (1999) Interferon-alpha and survival in metastatic renal carcinoma: early results of a randomised controlled trial. Lancet 353:14–17

3. Shevach EM (2004) Fatal attraction: tumors beckon regulatory T cells. Nat Med 10:900–901

4. Sakaguchi S, Sakaguchi N, Shimizu J, Yamazaki S, Sakihama T, Itoh M, Kuniyasu Y, Nomura T, Toda M, Takahashi T (2001) Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev 182:18–32

5. Takahashi T, Sakaguchi S (2003) The role of regulatory T cells in controlling immunologic self-tolerance. Int Rev Cytol 225:1–32

Cited by 176 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IFNγ Production by Functionally Reprogrammed Tregs Promotes Antitumor Efficacy of OX40/CD137 Bispecific Agonist Therapy;Cancer Research Communications;2024-08-01

2. Immunotherapy and stereotactic body radiotherapy for older patients with non-metastatic renal cancer unfit for surgery or decline nephrectomy: practical proposal by the International Geriatric Radiotherapy Group;Frontiers in Oncology;2024-05-24

3. Targeting CXCR4 impaired T regulatory function through PTEN in renal cancer patients;British Journal of Cancer;2024-05-04

4. Quantification of CD3, FoxP3, and granzyme B immunostaining in canine renal cell carcinoma;Veterinary Immunology and Immunopathology;2024-05

5. Cabozantinib in combination with immune checkpoint inhibitors for renal cell carcinoma: a systematic review and meta-analysis;Frontiers in Pharmacology;2024-04-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3